BRADFORD’S LAW OF SCATTERING AND LEIMKUHLER MODEL ON HIV VACCINE LITERATURE RESEARCH
Librarian
S.S. Dhamdhere Arts & Commerce College,
Talegaon Dhamdhere, Tal-Shirur, Dist-Pune
Email-gajbesumedh420@gmail.com
Librarian
G.E.I’s Mahila Mahavidyalaya,
S.V. Joshi Highschool, Dombivli(E) Dist-Thane. (MS) India
Email: gajbe.sankalp16@gmail.com
Librarian
South Indian Children’s Education Society’s
Degree College of Arts, Science and Commerce,
Jambhul Phata Ambernath (W) gajbesangharsh10@gmail.com
The study deals with the application of Bradford’s law of scattering on HIV Vaccine Research. It is found that verbal formulation 1: n: n2 has fit with the data on HIV Vaccine Research. As Leimkuher model applied for verification of Bradford’s law and it fits with 9:103:1145 geometric series with 11.16% of error. Other Scientometrics indicators such as the ranking of most preferred journals, geographical analysis of publication. ‘Vaccine’ is the highest preferred journal in the field of HIV Vaccine. The collected from PubMed published literature for period of 20 years from 2001-2020.
KEYWORDS: Bradford’s law, Leimkuhler model, HIV Vaccine Research, Bibliometrics,
Every field of knowledge developing tremendously and research are increasing with a variety of multidisciplinary approach. So, the nature of available journals and articles are very complex. In such situation it is very difficult for new researchers to find out relevant research materials. Even libraries have to think very carefully to procure the relevant reading materials to serve the users optimum. It is found that in every subject there are some journals which are referred frequently by researchers. It means these frequently cited journals are closer to the subject or research works.
These highly cited journals are called as ‘Central set of Journals. These journals are relevant and clearly reflect the conceptual essence of the research being carried out in the discipline. Generally, the number of these central journals are very less. These journals are reflecting not only the relevant materials but also interdisciplinary fields that are closely related to the subjects. Articles in such a central set of journals are concentrated on the content of related fields. Other rarely relevant journals are much in number and they only reflect the application of the subject in other disciplines.
The main objective of this study was to evaluate the HIV Vaccine publications using bibliometric techniques and to answer the following research objectives:
Based on the objectives of the study, we explored the bibliometric analysis of documents on HIV Vaccine using PUBMED database. A topical search was performed on June 18, 2021 using the term HIV vaccine to identify and obtain data on published literature for a period of 20 years .(2001- 2020). Total 10299 results were retrieved covering widespread subject fields. Searched for: TOPIC: (“HIV Vaccine”) this data from PUBMED Database.
Table 1 shows that a total of 10299 articles were published on HIV Vaccines
Year |
Articles |
Percentage |
2001 |
390 |
3.79 |
2002 |
409 |
3.97 |
2003 |
448 |
4.35 |
2004 |
453 |
4.40 |
2005 |
500 |
4.85 |
2006 |
473 |
4.59 |
2007 |
481 |
4.67 |
2008 |
509 |
4.94 |
2009 |
506 |
4.91 |
2010 |
532 |
5.17 |
2011 |
493 |
4.79 |
2012 |
508 |
4.93 |
2013 |
530 |
5.15 |
2014 |
605 |
5.87 |
2015 |
569 |
5.52 |
2016 |
636 |
6.18 |
2017 |
560 |
5.44 |
2018 |
569 |
5.52 |
2019 |
520 |
5.05 |
2020 |
577 |
5.60 |
2021 |
31 |
0.30 |
Total |
10299 |
100.00 |
Table 1 shows that a total of 10299 articles were published on HIV Vaccines during 2001-2020 thus on an average, approximately 513 articles were published each year. Maximum number of articles i.e. 636(6.18%) were published in the year 2016, whereas lowest number of articles i.e. 390 (3.79%) were published in 2001.
A total of 10299 articles were contributed in 1263 journals in the field of HIV Vaccines. Rank list of top 20 journals on basis of number of article published in each journal is given in the table 2. The top 20 most productive journals contained 4760(46.22%) of total articles. The maximum numbers of articles i.e. 765 (7.43%) were published in Journal of HIV Vaccines.
Table 2: Most Productive Journals
Sr.No. |
Journals |
Articles |
Percentage |
Rank |
1 |
VACCINE |
765 |
7.43 |
1 |
2 |
JOURNAL OF VIROLOGY |
594 |
5.77 |
2 |
3 |
PLOS ONE |
455 |
4.42 |
3 |
4 |
AIDS (LONDON ENGLAND) |
433 |
4.20 |
4 |
5 |
AIDS RESEARCH AND HUMAN RETROVIRUSES |
430 |
4.18 |
5 |
6 |
CURRENT OPINION IN HIV AND AIDS |
230 |
2.23 |
6 |
7 |
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (1999) |
200 |
1.94 |
7 |
8 |
THE JOURNAL OF INFECTIOUS DISEASES |
192 |
1.86 |
8 |
9 |
JOURNAL OF IMMUNOLOGY (BALTIMORE MD. : 1950) |
145 |
1.41 |
9 |
10 |
VIROLOGY |
140 |
1.36 |
10 |
11 |
IAVI REPORT : NEWSLETTER ON INTERNATIONAL AIDS VACCINE RESEARCH |
135 |
1.31 |
11 |
12 |
SCIENCE (NEW YORK N.Y.) |
135 |
1.31 |
11 |
13 |
PLOS PATHOGENS |
127 |
1.23 |
12 |
14 |
EXPERT REVIEW OF VACCINES |
113 |
1.10 |
13 |
15 |
CURRENT HIV RESEARCH |
109 |
1.06 |
14 |
16 |
INTERNATIONAL JOURNAL OF STD & AIDS |
103 |
1.00 |
15 |
17 |
NATURE |
98 |
0.95 |
16 |
18 |
NATURE MEDICINE |
97 |
0.94 |
17 |
19 |
HUMAN VACCINES & IMMUNOTHERAPEUTICS |
88 |
0.85 |
18 |
20 |
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA |
87 |
0.84 |
19 |
21 |
FRONTIERS IN IMMUNOLOGY |
84 |
0.82 |
20 |
|
Truncated…… |
|
|
|
MOST PRODUCTIVE JOURNALS |
< >Bradford's Law of Scattering:Table 3: Distribution of Journals on HIV Vaccines
Rank |
Journ al |
Cumulati ve Journals |
Articl es |
Total Articles |
Cumulativ e Articles |
Log N |
%Cumulative Articles |
%Cumulati ve Journals |
1 |
1 |
1 |
765 |
765 |
765 |
0.000 |
7.55 |
0.080 |
2 |
1 |
2 |
594 |
594 |
1359 |
0.693 |
13.40 |
0.159 |
3 |
1 |
3 |
455 |
455 |
1814 |
1.099 |
17.89 |
0.239 |
4 |
1 |
4 |
433 |
433 |
2247 |
1.386 |
22.16 |
0.318 |
5 |
1 |
5 |
430 |
430 |
2677 |
1.609 |
26.40 |
0.398 |
6 |
1 |
6 |
230 |
230 |
2907 |
1.792 |
28.67 |
0.477 |
7 |
1 |
7 |
200 |
200 |
3107 |
1.946 |
30.64 |
0.557 |
8 |
1 |
8 |
192 |
192 |
3299 |
2.079 |
32.54 |
0.636 |
9 |
1 |
9 |
145 |
145 |
3444 |
2.197 |
33.97 |
0.716 |
10 |
1 |
10 |
140 |
140 |
3584 |
2.303 |
35.35 |
0.796 |
11 |
2 |
12 |
135 |
270 |
3854 |
2.485 |
38.01 |
0.955 |
12 |
1 |
13 |
127 |
127 |
3981 |
2.565 |
39.26 |
1.034 |
13 |
1 |
14 |
113 |
113 |
4094 |
2.639 |
40.38 |
1.114 |
14 |
1 |
15 |
109 |
109 |
4203 |
2.708 |
41.45 |
1.193 |
15 |
1 |
16 |
103 |
103 |
4306 |
2.773 |
42.47 |
1.273 |
16 |
1 |
17 |
98 |
98 |
4404 |
2.833 |
43.44 |
1.352 |
17 |
1 |
18 |
97 |
97 |
4501 |
2.890 |
44.39 |
1.432 |
18 |
1 |
19 |
88 |
88 |
4589 |
2.944 |
45.26 |
1.512 |
19 |
1 |
20 |
87 |
87 |
4676 |
2.996 |
46.12 |
1.591 |
20 |
1 |
21 |
84 |
84 |
4760 |
3.045 |
46.95 |
1.671 |
21 |
1 |
22 |
72 |
72 |
4832 |
3.091 |
47.66 |
1.750 |
22 |
1 |
23 |
70 |
70 |
4902 |
3.135 |
48.35 |
1.830 |
23 |
1 |
24 |
68 |
68 |
4970 |
3.178 |
49.02 |
1.909 |
24 |
1 |
25 |
66 |
66 |
5036 |
3.219 |
49.67 |
1.989 |
25 |
1 |
26 |
61 |
61 |
5097 |
3.258 |
50.27 |
2.068 |
26 |
1 |
27 |
59 |
59 |
5156 |
3.296 |
50.85 |
2.148 |
27 |
1 |
28 |
58 |
58 |
5214 |
3.332 |
51.43 |
2.228 |
28 |
1 |
29 |
56 |
56 |
5270 |
3.367 |
51.98 |
2.307 |
29 |
1 |
30 |
56 |
56 |
5326 |
3.401 |
52.53 |
2.387 |
30 |
1 |
31 |
54 |
54 |
5380 |
3.434 |
53.06 |
2.466 |
31 |
2 |
33 |
52 |
104 |
5484 |
3.497 |
54.09 |
2.625 |
32 |
1 |
34 |
47 |
47 |
5531 |
3.526 |
54.55 |
2.705 |
33 |
1 |
35 |
46 |
46 |
5577 |
3.555 |
55.01 |
2.784 |
34 |
1 |
36 |
44 |
44 |
5621 |
3.584 |
55.44 |
2.864 |
35 |
6 |
42 |
38 |
228 |
5849 |
3.738 |
57.69 |
3.341 |
36 |
2 |
44 |
37 |
74 |
5923 |
3.784 |
58.42 |
3.500 |
37 |
1 |
45 |
36 |
36 |
5959 |
3.807 |
58.77 |
3.580 |
38 |
2 |
47 |
33 |
66 |
6025 |
3.850 |
59.42 |
3.739 |
39 |
2 |
49 |
32 |
64 |
6089 |
3.892 |
60.06 |
3.898 |
40 |
3 |
52 |
31 |
93 |
6182 |
3.951 |
60.97 |
4.137 |
41 |
2 |
54 |
30 |
60 |
6242 |
3.989 |
61.56 |
4.296 |
42 |
1 |
55 |
29 |
29 |
6271 |
4.007 |
61.85 |
4.375 |
43 |
1 |
56 |
27 |
27 |
6298 |
4.025 |
62.12 |
4.455 |
44 |
3 |
59 |
26 |
78 |
6376 |
4.078 |
62.89 |
4.694 |
45 |
6 |
65 |
25 |
150 |
6526 |
4.174 |
64.37 |
5.171 |
46 |
1 |
66 |
24 |
24 |
6550 |
4.190 |
64.60 |
5.251 |
47 |
1 |
67 |
23 |
23 |
6573 |
4.205 |
64.83 |
5.330 |
48 |
1 |
68 |
22 |
22 |
6595 |
4.220 |
65.05 |
5.410 |
49 |
2 |
70 |
21 |
42 |
6637 |
4.248 |
65.46 |
5.569 |
50 |
1 |
71 |
20 |
20 |
6657 |
4.263 |
65.66 |
5.648 |
51 |
5 |
76 |
19 |
95 |
6752 |
4.331 |
66.59 |
6.046 |
52 |
3 |
79 |
18 |
54 |
6806 |
4.369 |
67.13 |
6.285 |
53 |
8 |
87 |
17 |
136 |
6942 |
4.466 |
68.47 |
6.921 |
54 |
3 |
90 |
16 |
48 |
6990 |
4.500 |
68.94 |
7.160 |
55 |
11 |
101 |
15 |
165 |
7155 |
4.615 |
70.57 |
8.035 |
56 |
6 |
107 |
14 |
84 |
7239 |
4.673 |
71.40 |
8.512 |
57 |
14 |
121 |
13 |
182 |
7421 |
4.796 |
73.19 |
9.626 |
58 |
10 |
131 |
12 |
120 |
7541 |
4.875 |
74.38 |
10.422 |
59 |
14 |
145 |
11 |
154 |
7695 |
4.977 |
75.90 |
11.535 |
60 |
10 |
155 |
10 |
100 |
7795 |
5.043 |
76.88 |
12.331 |
61 |
10 |
165 |
9 |
90 |
7885 |
5.106 |
77.77 |
13.126 |
62 |
15 |
180 |
8 |
120 |
8005 |
5.193 |
78.95 |
14.320 |
63 |
26 |
206 |
7 |
182 |
8187 |
5.328 |
80.75 |
16.388 |
64 |
33 |
239 |
6 |
198 |
8385 |
5.476 |
82.70 |
19.014 |
65 |
36 |
275 |
5 |
180 |
8565 |
5.617 |
84.48 |
21.877 |
66 |
62 |
337 |
4 |
248 |
8813 |
5.820 |
86.92 |
26.810 |
67 |
96 |
433 |
3 |
288 |
9101 |
6.071 |
89.76 |
34.447 |
68 |
214 |
647 |
2 |
428 |
9529 |
6.472 |
93.98 |
51.472 |
69 |
610 |
1257 |
1 |
610 |
10139 |
7.136 |
100.00 |
100.000 |
Table 4: Zone wise Distribution of Journals
Zone Journals |
Journals |
Journals% age |
Articles |
Articles %age |
Multiplier |
1 |
9 |
0.72 |
3444 |
33.44 |
|
2 |
76 |
6.05 |
3454 |
33.54 |
8.44 |
3 |
1172 |
93.24 |
3401 |
33.02 |
15.42 |
|
1257 |
100 |
10299 |
100 |
11.93 |
According to Bradford's law, the zones, thus identified will form an approximately geometric series in the form 1: n: n2 . The relationship of each zone in the present study is 9:76: 1172. Here 9 denotes the number of journals in the Nucleus and the mean Bradford multiplier is 11.93.
Therefore expression can be given as:
9: 9 x (11.93): 9 x (11.93)2 :: 1: n: n2
9: 107.37: 1280.92 > 1397.29
% error =(1397.29 -1257) / 1257 * 100 = 11.16%
It is clear that percentage of error is not so high and hence the Data will fit in Bradford's Law.
A Scatter graph is plotted of the cumulative number of articles with the log of cumulative number of journals to show Bradford zones.
In this study both Bradford’s law as well as Leimkuhler models are tested to verify the scattering of literature on HIV Vaccine (Leimkuhler, 1967). Leimkuhler developed a model based on Bradford’s verbal formulation as shown below:
R(r)= a log (1+br)
Where, r = 1,2,3……
Egghe explained the Leimkhuler model as (Egghe, 1990):
a = Y0 / log k b = k – 1 / r0
here r0 - is the number of sources in the first Bradford group
Y0 – the number of items in every Bradford group (all these group of items being of equal sizes), and
k – the Bradford multiplier
R(r) is the cumulative number of items produced by the sources of rank 1,2,3…. r a and b are constants appearing in the law of Leimkuhler (Leimkuhler, 1980). Egghe (1990) has shown the mathematical formula for calculating the Bradford Multiplier k as
k= (ey ym )1/p
Where ???? is Euler’s number (e y =1.781) e = 2.718 (constant)
p = 3
If the sources are ranked in decreasing order of productivity, then ym is the number of items in the most productivity sources.
ro = number of journals in Bradford’s first zone T = Total number of journals in Bradford zone
k = (1.781*Ym)1/p = (1.781*765)1/3 = (91362.465)1/3=11.086
Yo = A/P = 10299/3 = 3433
ro =T (k-1)/(kp-1) = 1257(10.086)/(11.086)3-1
=1257*10.086/(11.086*11.086*11.086)-1
= 12678.102/1362.4627-1
=12678.102/1361.4627 ro=9.3121
r1= r0*k = 9.3121*11.086
= 103.239
r2= r0*k2 = 9.1321*(11.086)2
= 1144.451
a = Y0/log K = 3433/log 11.86 = 3433/1.04477
=3285.8906
b = k-1/ro = 10.086/10.2353
= 0.9854
The findings are shown in Table 7
From Table 7, the number of journals in the nucleus is found to be 9.2353 and k=11.086.31
Therefore expression can be given as:
9: 9 x (11.27): 9 x (11.27)2:: 1: n: n2
9: 101.43: 1143. > 1397.29
% error = (1397.29 -1257) / 1257 * 100 = 11.16%
It is clear that percentage of error is not so high and hence the Data will fit in Bradford's Law.
Bradford’s law of scattering in the area of HIV Vaccine.
As per the Leimkuher model Bradford’s zone of cited journals are as follow:
Table 5: Zone wise Distribution of Journals Leimkuher model Bradford’s zone
Zone Journals |
Journals |
Journals% age |
No. of Citation |
Multiplier |
1 |
9 |
0.72 |
3444 |
|
2 |
103 |
8.19 |
3977 |
11.44 |
3 |
1145 |
91.09 |
2718 |
11.11 |
Total |
1257 |
100 |
10139 |
11.27 |
Table 6: Language wise Distribution
Sr. No. |
Language |
No of time |
Percentage |
1 |
English |
10268 |
97.51 |
2 |
Chiness |
58 |
0.55 |
3 |
French |
50 |
0.47 |
4 |
German |
35 |
0.33 |
5 |
Japness |
29 |
0.28 |
6 |
Russian |
22 |
0.21 |
7 |
French |
12 |
0.11 |
8 |
Polish |
9 |
0.09 |
9 |
Spanish |
15 |
0.14 |
10 |
Portuguese |
10 |
0.09 |
11 |
Italian |
6 |
0.06 |
12 |
Dutch |
4 |
0.04 |
13 |
Norwegian |
3 |
0.03 |
14 |
Hebrew |
3 |
0.03 |
15 |
Czech |
3 |
0.03 |
16 |
Swedish |
2 |
0.02 |
17 |
Lithuanian |
1 |
0.01 |
|
Total |
10530 |
100 |
Table No. 6 is about ranking of Language wise distribution. It shown that the journal published in English language at the top stage i.e. 6406 (85.36%), while at the second stage is Japanese with 348 (i.e.4.64%), There are article is published in French 205 (i.e.2.73%), after that Portuguese is 169 (2.25%) and Spanish languages with i.e.1.59% and 119 articles published.
While analyzing list of journals cited it becomes essential to determine geographical scattering of periodicals and thereby that of citations. The countries of origin of all publications could not ascertain from the citations themselves. These were obtained from the searching internet of their website. Rank list of countries with the number of journals and citations shown in table no. 7
Table No.7: Country of publication
Sr. No. |
Country |
Count |
Percentage |
Rank |
1 |
UNITED STATES |
5038 |
48.92 |
1 |
2 |
ENGLAND |
2588 |
25.13 |
2 |
3 |
NETHERLAND |
1346 |
13.07 |
3 |
4 |
SWITZERLAND |
155 |
1.51 |
4 |
5 |
GERMANY |
145 |
1.41 |
5 |
6 |
CHINA |
92 |
0.89 |
6 |
7 |
FRANCE |
92 |
0.89 |
6 |
8 |
SPAIN |
58 |
0.56 |
7 |
9 |
UNITED ARAB EMIRATES |
58 |
0.56 |
8 |
10 |
CANADA |
54 |
0.52 |
9 |
11 |
SOUTH AFRICA |
49 |
0.48 |
10 |
12 |
DENMARK |
46 |
0.45 |
11 |
13 |
UGANDA |
42 |
0.41 |
12 |
14 |
INDIA |
41 |
0.40 |
13 |
15 |
JAPAN |
40 |
0.39 |
14 |
16 |
BRAZIL |
30 |
0.29 |
15 |
17 |
RUSSIA (FEDERATION) |
24 |
0.23 |
16 |
18 |
ITALY |
22 |
0.21 |
17 |
19 |
AUSTRIA |
20 |
0.19 |
18 |
20 |
WASHINGTON (DC) NEW YORK |
20 |
0.19 |
18 |
21 |
AUSTRALIA |
19 |
0.18 |
19 |
22 |
BELGIUM |
18 |
0.17 |
20 |
23 |
IRAN |
15 |
0.15 |
21 |
24 |
IRELAND |
15 |
0.15 |
21 |
25 |
NEW ZEALAND |
13 |
0.13 |
22 |
26 |
POLAND |
12 |
0.12 |
23 |
27 |
THAILAND |
12 |
0.12 |
23 |
28 |
AFRICA |
11 |
0.11 |
24 |
29 |
SCOTLAND |
11 |
0.11 |
24 |
30 |
9 time Cited journal Country (9 x3) |
27 |
0.26 |
25 |
31 |
8 time Cited journal Country (8 x1) |
8 |
0.08 |
26 |
32 |
6 time Cited journal Country (6 x2) |
12 |
0.12 |
27 |
33 |
5 time Cited journal Country (5 x4) |
20 |
0.19 |
28 |
34 |
4 time Cited journal Country (4 x3) |
12 |
0.12 |
29 |
35 |
3 time Cited journal Country (3 x1) |
3 |
0.03 |
30 |
36 |
2 time Cited journal Country (2 x6) |
12 |
0.12 |
31 |
37 |
1 time Cited journal Country (1 x16) |
16 |
0.16 |
32 |
38 |
NOT AVAILABLE |
103 |
1.00 |
33 |
PUBLICATION OF COUNTRY
AUSTRIA RUSSIA (FEDERATION) JAPAN UGANDA SOUTH AFRICA UNITED ARAB EMIRATES FRANCE GERMANY NETHERLAND UNITED STATES 0 1000 2000 3000 4000 5000 6000 |
Fig.No.3 Country wise Publication
Table no.7 observed that, United States with 5038 (17.06) on first rank, followed by United Kingdom 2588 (16.16%) and Netherland 1346(%)on third rank
As this bibliometric analysis draws on publicly available data and does not directly involve human participants, ethical review is not required. Results of this analysis will identify the trends in HIV
Vaccine research publications.in terms of HIV vaccine site being studied as well as the type of research being conducted. This study will also highlight strengths, weaknesses and opportunities in areas such as the quality and type of research being conducted and could be used to guide the allocation of HIV Vaccine research.
Reference